Pharma Focus Asia

With time, nutraceuticals are becoming increasingly demanding in the global as well as Indian markets. According to Grand View Research, the India nutraceuticals market size is projected to grow at a CAGR of 13.5% from 2024 to 2030

As the industry continues its innovation spree across small and large molecules, Tech-enabled drug discovery vendors are re-establishing themselves as digital biotechnology companies with in-house therapeutic pipelines along-with platform-based and project-based partnerships to pharma players. Also, incorporating integrated AI-driven solutions in clinical trial design will aid in reducing costs, timelines and increasing efficiency through DCT models

The industry can play a crucial role in bridging the gaps by strengthening global supply chains, ensuring equity of pricing strategies, effecting technology transfers, signing voluntary licensing agreements, and participating in institutional tenders through competitive bidding

Asia's healthcare landscape is undergoing a transformative journey, grappling with profound challenges in changing demographics, persistent health inequities, and the rising burden of increased disease prevalence

The discovery of artificial radioactivity triggered the birth of nuclear medicine, which is a peculiar medical specialty able to depict pathophysiological processes in the human body by using radiopharmaceuticals. Thus, radiolabelling and radio imaging play a crucial role in disease management.

In the complex landscape of Pharmacy Benefit Management (PBM), combatting Fraud, Waste, and Abuse (FWA) has emerged as a critical challenge. This article explores innovative, real-time techniques for PBMs to navigate the intricacies of FWA

Therapeutic peptides are a promising frontier in precise medicine, leveraging unique properties for targeted treatment. Advancements in production, modification, and delivery have surmounted challenges.

The successful introduction of commercial lipidic formulations of cyclosporine as Sandimmune in 1981, followed by its reformulation as Neoral, has raised interest of the lipid-based drug delivery technology over the past two decades.1 With a greater understanding of the various functions lipids may have in boosting oral bioavailability

Innovation and operational excellence are two important pillars of Bachem’s success. Thus, to keep technological leadership and high-quality services, it was essential to start our digital transformation and to enter the Industry 4.0 area. This will benefit our customers, as we will be able to increase our capacity.

pharmaceutical industry, technology-driven approach, drug discovery and development, pharma news, manufacturing processes, supply chain management, healthcare trends, drug pricing and reimbursement, Asian healthcare market, pharma industry insights

Explore the latest advancements in plant miRNA research and its potential for disease prevention. Stay updated with pharmaceutical industry insights, drug research and development, and healthcare trends in Asia.

Lemongrass extract modulates wound-repairing macrophages, which affect the wound microenvironment, efferocytosis, resolve inflammation, and regenerate tissue to heal wounds.

In recent trials, nanoparticles were discovered to be effective in the delivery of COVID-19 medications. In many circumstances, it has been seen that patients receiving drugs provided through nanoparticles have absolutely minimal negative effects.

Hyperlipidemia has been shown to directly lead to diseases like cardiovascular disease, cancer, Type II Diabetes and Alzheimer’s disease.

Homeopathy a controversial medical system discovered by a German physician Samuel Hahnemann (1755–1843) was first postulated at the end of the 18th century and mentioned in the first edition of his Organon in 1810.(1) In such anecdotal times, where theories about the deficiency, four bodily fluids, theories about “corrupted juices” were propagating, against all odds, the beginning of pre‐scientific medical theories were booming with evidence

Novel, robust biomarker identification during drug development poses immense potential for treating incurable diseases. Novel, robust biomarker identification during drug development poses immense potential for treating incurable diseases.
https://www.pharmafocusasia.com/clinical-trials/biomarkers-in-drug-discovery

PHARMACEUTICAL TRENDS
Nilesh Shah shares his insights into the shift for more hospital-to-home treatment options for chronic conditions and how health care providers and pharmaceutical companies can collaborate to address any potential gaps to enhance patient care at home.

Quris pioneers a groundbreaking bio-AI platform, merging advanced AI with innovative biology to revolutionise drug discovery.
https://www.pharmafocusasia.com/information-technology/problem-for-pharma-companies-using-groundbreaking